Efficacy and safety of camrelizumab combined with FOLFOX as neoadjuvant therapy for patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy.
Yuzhou Zhao(Capital Medical University), Xijie Zhang(Zhengzhou University), Jinbang Wang(Dalian National Laboratory for Clean Energy), Chen-Yu Liu(Institute on Governance), Guangsen Han(Zhengzhou University), Gangcheng Wang(Zhengzhou University), Sen Li(Xi'an Jiaotong University), Pengfei Ma(First Affiliated Hospital of Zhengzhou University), Junli Zhang(Target (United States)), Yanhui Gu(Zhengzhou University), Zhimeng Li(Zhengzhou University), Jing Zhuang(Zhengzhou University), Yanghui Cao(Zhengzhou University), Baodong Li(Zhengzhou University)
Cited by 2
Related Papers
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2019|324
Direct Observation of Cyclic Carbenium Ions and Their Role in the Catalytic Cycle of the Methanol‐to‐Olefin Reaction over Chabazite Zeolites
|Angewandte Chemie International Edition|2013|238
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer
|Nature Communications|2017|78
Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a/JAK2/STAT3 signaling
|Annals of Translational Medicine|2020|71